Erik Steinberg is Director of Allied Medical Governance at GlaxoSmithKline Pharmaceuticals (GSK). He has been leading pharmaceutical research and development activities for multiple companies for the past 30 years. Erik’s expertise is ensuring compliance with worldwide federal regulations in the development of new medications. Presently, he is directing risk management activities making sure all patients are GSK’s number one priority.